Johnson, S. S., Liu, D., Ewald, J. T., Robles-Planells, C., Pulliam, C., Christensen, K. A., . . . Fath, M. A. Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth. Taylor & Francis Group.
Chicago Style (17th ed.) CitationJohnson, Spenser S., et al. Auranofin Inhibition of Thioredoxin Reductase Sensitizes Lung Neuroendocrine Tumor Cells (NETs) and Small Cell Lung Cancer (SCLC) Cells to Sorafenib as Well as Inhibiting SCLC Xenograft Growth. Taylor & Francis Group.
MLA (9th ed.) CitationJohnson, Spenser S., et al. Auranofin Inhibition of Thioredoxin Reductase Sensitizes Lung Neuroendocrine Tumor Cells (NETs) and Small Cell Lung Cancer (SCLC) Cells to Sorafenib as Well as Inhibiting SCLC Xenograft Growth. Taylor & Francis Group.